The Man Who Recommended 23 1,000% Winners Is Revealing His #1 Stock for 2020

You’ll get the name & ticker of Matt McCall’s top pick when you tune in to his FREE event.

Tue, October 20 at 4:00PM ET

U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020

Keep an eye on these American names that boast lower valuations and big potential

Do you have big questions about what to expect in the new year? Or are you a loyal Twitter (NYSE:TWTR) follower of Matt McCall? Either way, he’s got you covered in this episode of “Moneyline.” He’s here to wish you “happy holidays” and answer the top questions about 2020’s major themes.

Source: InvestorPlace

Cannabis stocks have been a hot topic in 2019. After soaring to reach new highs in the beginning of the year, the big names have all tanked. Aurora Cannabis (NYSE:ACB), Canopy Growth (NYSE:CGC) and Cronos (NASDAQ:CRON) are all sporting year-to-date losses of more than 30%. Many investors fear that 2020 will bring trouble for companies in “cash crunches.” But McCall isn’t too worried about what he sees as the solid names in the business.

For investors looking to get in at good valuations, he’s recommending U.S. pot stocks that trade at much lower price-to-sales ratios than their Canadian peers. This next year might just bring U.S. legalization at the federal level and send cannabis stocks blazing.

Want to learn more about other high-risk, high-reward investments? McCall next dives into bitcoin and other cryptocurrency plays. After looking at historical trends, he concludes that 2020 will be a big year for bitcoin. It could hit $50,000 or even $100,000 in the next few years. But perhaps more exciting are alternative coins. These alt-coins are ready for huge growth, but be careful. Don’t put all your retirement money in these cryptocurrencies.

McCall’s Podcast

McCall’s listeners have him hopping across the world for 2020’s next major themes. After cannabis and crypto, it’s time for Chinese stocks. Boy, that’s an alliterative mouthful. You might remember that he recently traveled to China to do research, and he’s still confident about the upside potential there. He’s bullish on a peer-to-peer lending company and some biotech names.

It wasn’t until 2018 that Hong Kong’s stock exchange allowed pre-revenue biotech companies to list. But now, it seems likely that a few of these names will parallel the likes of Amgen (NASDAQ:AMGN). It’s likely McCall will be making a return trip to China in 2020, so keep your eyes peeled for more updates. With a trade deal resolution hopefully right around the corner, there’s a lot to like in terms of Chinese stocks.

For more on McCall’s 2020 predictions, solar stocks and wind stocks, tune into “Moneyline.” You’ll get an update about his holiday travel plans and more on an upcoming IPO product, too.

Matthew McCall left Wall Street to actually help investors — by getting them into the world’s biggest, most revolutionary trends BEFORE anyone else. The power of being “first” gave Matt’s readers the chance to bank +2,438% in (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities. 

Article printed from InvestorPlace Media,

©2020 InvestorPlace Media, LLC